Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

AMINOSYN 3.5% M

AMINO ACIDS; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE

Standard Dose
3.5%;21MG/100ML;128MG/100ML;234MG/100ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview AMINOSYN 3.5% M is listed in Drugs@FDA under application 017789 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient AMINO ACIDS; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE Form and strength INJECTABLE;INJECTION - 3.5%;21MG/100ML;128MG/100ML;234MG/100ML Sponsor ICU MEDICAL INC Submission history Latest submission status date: 2003-06-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview AMINOSYN 3.5% M is listed in Drugs@FDA under application 017789 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient AMINO ACIDS; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE Form and strength INJECTABLE;INJECTION - 3.5%;21MG/100ML;128MG/100ML;234MG/100ML Sponsor ICU MEDICAL INC Submission history Latest submission status date: 2003-06-12 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
AMINOSYN 3.5% M (AMINO ACIDS; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE) | Drug Monograph | MedicHelpline